Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1973/12/01 by Cheng Yung-Chi, Yung-Chi Cheng, William H. Prusoff · 59 citations
Biochemistry, Genetics and Molecular Biology · #Receptor Mechanisms and Signaling #Viral Infectious Diseases and Gene Expression in Insects #Protein purification and stability

paper · doi:10.1016/0006-2952(73)90196-2

Cited by

• Antiallodynic and antihyperalgesic activity of new 3,3-diphenyl-propionamides with anticonvulsant activity in models of pain in mice
• Resveratrol Acts as a Mixed Agonist/Antagonist for Estrogen Receptors α and β*
• Neurochemical and Behavioral Effects of Ciproxifan, A Potent Histamine H3-Receptor Antagonist
• Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites
• Kinetic and Thermodynamic Assessment of Binding of Serotonin Transporter Inhibitors
• Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
• Orthosteric and Allosteric Modes of Interaction of Novel Selective Agonists of the M1 Muscarinic Acetylcholine Receptor
• Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist
• A Novel Multivalent Ligand That Bridges the Allosteric and Orthosteric Binding Sites of the M2 Muscarinic Receptor
• Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
• Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
• Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)
• Prospective evaluation of structure-based simulations reveal their ability to predict the impact of kinase mutations on inhibitor binding
• Strategic design of GalNAc-helical peptide ligands for efficient liver targeting
• Comprehensive Predictions of Cytochrome P450 (P450)-Mediated In Vivo Cannabinoid-Drug Interactions Based on Reversible and Time-Dependent P450 Inhibition in Human Liver Microsomes
• Microbial ureases: significance, regulation, and molecular characterization
• Analgesic effects of ivermectin, baicalin, and DL-kavain in a mouse model of thermal hypersensitivity correlate with modulation of recombinant alpha3 glycine receptor function
• D3R Grand Challenge 2: blind prediction of protein–ligand poses, affinity rankings, and relative binding free energies
• Expanding the DNA damaging potential of artificial metallo-nucleases with click chemistry
• Characterization of the Two-Domain Peptide Binding Mechanism of the Human CGRP Receptor for CGRP and the Ultrahigh Affinity ssCGRP Variant
• Contributions of water transfer energy to protein‐ligand association and dissociation barriers: Watermap analysis of a series of p38α MAP kinase inhibitors
• Design, synthesis, and in vitro–in silico evaluation of indazolyl oxadiazole hybrids as promising anticancer candidates
• Efficient Binding Affinity Estimation for Fragment-Based Compounds Using a Separated Topologies Approach
• β-Adrenergic receptors on murine lymphocytes: Density varies with cell maturity and lymphocyte subtype and is decreased after antigen administration
• Demystifying Functional Parameters for Irreversible Enzyme Inhibitors
• Heterogeneity between insulin and proinsulin in the potency for insulin autoantibodies in newly diagnosed type 1 diabetes children
• Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands
• Steroidal A/B-ring fusion as a strategy for isoform-selective inhibition of human carbonic anhydrases
• ImmunoAI: Accelerated Antibody Discovery Using Gradient-Boosted Machine Learning with Thermodynamic-Hydrodynamic Descriptors and 3D Geometric Interface Topology
• Chemistry, Crystal Structure, and In Vitro Receptor Binding of Δ10-THC Isomers
• Receptor binding studies disclose a novel class of high‐affinity inhibitors of the Escherichia coli FimH adhesin
• Integration of In Vitro and In Silico Approaches Enables Prediction of Drug-Induced Liver Injury
• Slow conformational dynamics of the human A2A adenosine receptor are temporally ordered
• A high quality, industrial data set for binding affinity prediction: performance comparison in different early drug discovery scenarios
• G-protein-coupled receptor heterodimerization modulates receptor function. [europepmc]
• Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. [europepmc]
• Peroxidase activity and structural transitions of cytochrome c bound to cardiolipin-containing membranes. [europepmc]
• Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. [europepmc]
• Illuminating insights into firefly luciferase and other bioluminescent reporters used in chemical biology. [europepmc]
• Jasmonate perception by inositol-phosphate-potentiated COI1-JAZ co-receptor. [europepmc]
• Mixed-affinity binding in humans with 18-kDa translocator protein ligands. [europepmc]
• The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor. [europepmc]
• Analysis of protein-ligand interactions by fluorescence polarization. [europepmc]
• A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1. [europepmc]
• Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. [europepmc]
• 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer. [europepmc]
• Fluorescence polarization assays in small molecule screening. [europepmc]
• HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity. [europepmc]
• Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement. [europepmc]
• Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes. [europepmc]
• In silico methods for drug repurposing and pharmacology. [europepmc]
• Histone deacetylase 6 structure and molecular basis of catalysis and inhibition. [europepmc]
• Cannabinoid CB 2 receptor ligand profiling reveals biased signalling and off-target activity. [europepmc]
• T cells from patients with Parkinson's disease recognize α-synuclein peptides. [europepmc]
• Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport. [europepmc]
• Virtual discovery of melatonin receptor ligands to modulate circadian rhythms. [europepmc]
• Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels. [europepmc]
• Drug-target affinity prediction using graph neural network and contact maps. [europepmc]
• Structure and specificity of nuclear receptor-coactivator interactions. [europepmc]